DexCom Analyst Price Targets - Benzinga

DexCom Inc

DXCMNASDAQ

Trade with Public

Trade with Public

$81.14

-4.59-5.36%

마지막 업데이트: Oct 21, 11:22 AM

$83.70

-2.04-2.38%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

DexCom Analyst Price Targets - Benzinga

DexCom Analyst Price Targets

Wall Street analyst price targets and consensus rating for DexCom (DXCM).

Price Target Range — 9 Quarters

Analyst Consensus — 26 Analysts

1S.Buy

23Buy

2Hold

Consensus RatingBuy# Analysts26Avg. Consensus PT$91Upside to Avg. PT+12.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$90→$96
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$115
Oct 1, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$90→$105
Sep 18, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$93→$102
Sep 18, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$95
Aug 4, 2026	Argus Research	Steve Silver	PT Raise	Buy	$86→$96
Aug 3, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$82→$90
Jul 31, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$84→$88
Jul 31, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$85→$90
Jul 31, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$90→$95
Jul 31, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$65→$82
Jul 31, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$88→$95
Jul 31, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$85→$90
Jul 31, 2026	Stifel	Jonathan Block	PT Raise	Buy	$90→$95
Jul 31, 2026	Benchmark	Bruce D. Jackson	PT Raise	Buy	$77→$82
Jul 31, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$87→$93
Jul 31, 2026	BTIG	Marie Thibault	PT Raise	Buy	$80→$90
Jul 28, 2026	UBS	Patrick Wood	Reinstates	Buy	$96
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$80→$87
Jul 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$85→$90

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Maintains Buy on DexCom, Raises Price Target to $96

BTIG analyst Ryan Zimmerman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $115

Barclays analyst Christopher Pasquale initiates coverage on DexCom (NASDAQ:DXCM) with a Overweight rating and announces Price Target of $115.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105

RBC Capital analyst Kendall Au maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $105.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on DexCom, Raises Price Target to $102

Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $93 to $102.

Benzinga Newsdesk

PRO
TD Cowen Reiterates Buy on DexCom, Maintains $95 Price Target

TD Cowen analyst Joshua Jennings reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $95 price target.

Benzinga Newsdesk

PRO
Argus Research Maintains Buy on DexCom, Raises Price Target to $96

Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.

Benzinga Newsdesk